Evaluation of the efficiency and safety of tocilizumab therapy in patients with systemic-onset juvenile idiopathic arthritis: results of a retrospective follow-up

Objective: to study the efficiency and safety of tocilizumab (TCZ) therapy in patients with systemic-onset juvenile idiopathic arthritis (sJIA). Patients and methods. The retrospective study included 48 children with active sJIA in whom TCZ therapy was initiated because of the inefficiency of using...

Descrizione completa

Dettagli Bibliografici

Autori principali:	M. M. Kostik, E. A. Isupova, I. A. Chikova, M. F. Dubko, V. V. Masalova, L. S. Snegireva, O. V. Kalashnikova, V. G. Chasnyk
Natura:	Artigo
Lingua:	Russo
Pubblicazione:	IMA-PRESS LLC 2018-01-01
Serie:	Современная ревматология
Soggetti:	systemic juvenile idiopathic arthritis interleukin-6 tocilizumab remission
Accesso online:	https://mrj.ima-press.net/mrj/article/view/793
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!